# Safety Study of NNZ-2566 in Healthy Female Subjects

> **NCT00961779** · PHASE1 · COMPLETED · sponsor: **Neuren Pharmaceuticals Limited** · enrollment: 39 (actual)

## Conditions studied

- Brain Injuries, Traumatic

## Interventions

- **DRUG:** NNZ-2566
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00961779
- **Lead sponsor:** Neuren Pharmaceuticals Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-08
- **Final completion:** 2010-09
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2014-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00961779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00961779, "Safety Study of NNZ-2566 in Healthy Female Subjects". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00961779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*